Ventricular tachycardia predicts all-cause mortality and non-sudden cardiac death in non-ischaemic cardiomyopathy

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): The DCM-VT study was partially supported by an investigator-initiated grant (IIS-310) from Biosense Webster (a Johnson & Johnson company). The DANISH study was supported by unrestricted grants from Medtro...

Descripción completa

Detalles Bibliográficos
Autores principales: Omara, S, Godsk, T S, Koeber, L, Thune, J J, Pehrson, S, Tedrow, U B, Ebert, M, Carbucicchio, C, Berruezo, A, Vaseghi, M, Deneke, T, Wijnmaalen, A P, Stevenson, W G, Nielsen, J C, Zeppenfeld, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
13.2 - Epidemiology, Prognosis, Outcome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207166/
http://dx.doi.org/10.1093/europace/euad122.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207166/
http://dx.doi.org/10.1093/europace/euad122.281

Ejemplares similares